Interdisciplinary Health Research Team in Musculoskeletal Neoplasia, Canada

Registration Status: Completed

Objective: Interdisciplinary Health Research Team (IHRT) in Musculoskeletal (MSK) Neoplasia is the result of a unique collaboration between clinicians and basic scientists who represent a comprehensive cross-section of geographic and professional constituencies. The health issues under investigation in the application are the pathogenesis, treatment and treatment-related morbidity of primary malignant tumours (sarcomas) of the bones and soft tissues and the benign lesions that are often associated with sarcoma. These diseases affect up to 2% of Canadians1 and represent an important health issue.

Registered Biobank Name Interdisciplinary Health Research Team in Musculoskeletal Neoplasia
Biobank Leader Co-Investigators: Dr. Jay Wunder, Dr. Rita Kandel, Dr. Irene Andrulis, Dr. Aileen Davis, Dr. Richard Hill, Dr. David Malkin, Dr. Ben Alman; Associate: Dr. Robert Turcotte, Dr. Bas Masri, Dr. Brian O’Sullivan, Dr. Joel Werier, Dr. Marc Isler
Country Canada
Email for biobank inquiries
Principal Investigator Dr. Robert S. Bell, Department of Surgery, Mount Sinai Hospital
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: